Mercola
Story at-a-glance
- While Pfizer claims its vaccine is 95% effective, this is the relative risk reduction. The absolute risk reduction — which is far more relevant for public health measures — is actually less than 1%
- While benefits from COVID “vaccination” in children between the ages of 12 and 15 are rare and short-lived, side effects are common and long-term effects are completely unknown
- In the 12-to-15 age group, 75.5% experienced headache, along with a long list of other transient side effects. Serious systemic adverse events occurred in 2.4% of the trial subjects receiving Pfizer’s mRNA shot
- While Pfizer boasted a 100% efficacy rate in 12- to 15-year-olds, this conclusion is a statistical trick. Fewer than 2% of fully vaccinated children avoided COVID-19; 98% of them would not have gotten COVID anyway. So, the benefit is small
- Even if vaccinating children were found to reduce infection among adults, it would be unethical and against regulations to do so, because the FDA can only authorize the use of a medical product in a given population if the benefit outweighs the risk in that same population, and in children the benefits do not outweigh the risks
WATCH VIDEO & READ FULL ARTICLE HERE > https://articles.mercola.com/sites/articles/archive/2021/06/29/children-covid-vaccine.aspx